Pregnancy induction of labor when uterine curettage in the Palace of Music TMVCu IUD placement of 120 Cases.doc

 PAGE \* MERGEFORMAT 8 Pregnancy induction of labor when uterine curettage in the Palace of Music TMVCu IUD placement of 120 Cases [Abstract] Objective To investigate the induction of labor uterine curettage in pregnancy when the contraceptive effect of IUD insertion and feasibility. A group observed set of lines in the site selection procedures inducing pregnancy, and long-term contraceptive measures required to implement and no place IUD contraindications 120 cases of women in the control group, B group selected a clean period required 3 to 7 days after IUD insertion for women with no contraindications 120 cases (those not included in the study lost range). Results curettage abortion when the pregnancy was no IUD uterine perforation, infection, no bleeding after placement, the contraceptive effectiveness and adverse reactions with the menstrual clean, 3 to 7 days after the IUD placed no significant difference. Conclusion curettage abortion when the pregnancy IUD insertion is safe and feasible. [Keywords:] in pregnancy induction of labor curettage; IUD; feasibility Intrauterine device (IUD) because of its safe, effective, convenient, reversible, in our country plays an important role of family planning measures. In order to meet women in unexpected pregnancy after termination of pregnancy, strong demand for contraception, pregnancy induction of labor in this study cleared Palace of surgery when the clinical effect of IUD insertion. confirmed with the menstrual clean place after 3 to 7 days without serious complications, like, a very good contraceptive effect, and accepted by the majority of women. 1 Materials and Methods 1.1 General Information for the February 2006 to August 2007 in the site line to request pregnancy curettage abortion IUD insertion in 120 cases of healthy women, aged 20 to 40 years, previous menstrual regularity, non-gynecological diseases No intrauterine tissue residue, no reproductive tract abnormalities, hemoglobingt; = 9.0